Skip to main content

WATSON 3219 Pill - green & yellow capsule/oblong, 29mm

Pill with imprint WATSON 3219 is Green & Yellow, Capsule/Oblong and has been identified as Aspirin, Butalbital and Caffeine 325 mg / 50 mg / 40 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine is used in the treatment of Migraine; Headache; Pain and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3219

Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219

Aspirin, Butalbital and Caffeine

Imprint
WATSON 3219
Strength
325 mg / 50 mg / 40 mg
Color
Green & Yellow
Size
29.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
microcrystalline cellulose, corn starch, magnesium silicate, D&C Yellow No. 10, FD&C Green No. 3, gelatin, ferric oxide red

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3219 (Discontinued) Watson Pharmaceuticals, Inc.
68084-0934 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.